News
PBD Biotech broadens patent for tuberculosis diagnostic
PBD Biotech has received grant of its patent application for Actiphage – its incipient tuberculosis (TB) diagnostic – within the regional African Intellectual Property Organization (OAPI).
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
PBD Biotech has received grant of its patent application for Actiphage – its incipient tuberculosis (TB) diagnostic – within the regional African Intellectual Property Organization (OAPI).